The Benevolent Investor: Institutional Ventures Grow In Size And Reach
This article was originally published in Start Up
A growing number of medical research institutions are investing in start-ups as a venture capitalist would, at times in new companies that have only tangential ties to the home institution.
You may also be interested in...
Digital health is no longer a buzzword but a reality, with venture capital investment in this space reaching an all-time high. This Q&A with Jordan Kramer of Kaiser Permanente Ventures provides insight into why digital health investment has rocketed, how Kaiser Permanente's approach to investing in this sector, and where the opportunities and challenges lie for digital health start-ups.
Versant Ventures joined the ranks of venture capital firms closing new funds recently, thanks in part to the swell in biotech initial public offerings this year. Versant’s Fund V represents an oversubscribed level of approximately $55 million to its intended $250 million target.